Connect with us

Business

Pharmacyte Biotech Inc (NASDAQ: PMCB) Made an Official Statement that Encapsulation Material Does Not Change Cellular DNA

Published

on

Pharmacyte Biotech Inc (NASDAQ: PMCB) has left the scientific and medical community thinking. The biotechnology company is focused on developing cellular therapies for cancer and diabetes has made an announcement about encapsulation material. According to one of the latest statements issued by the group, it has come to light that encapsulation material in no form can alter cellular DNA.

Group announced results from the third test of biocompatibility

Recently, the company announced results obtained from the third round of tests involving biocompatibility of its CypCaps™ product, which is a candidate for pancreatic cancer. According to the test results, it is proved that any empty capsule material is not mutagenic by any means. However, when probed what a mutagenic is, it has come to light that any physical or chemical agent armed with the ability to permanently alter genetic material, predominantly DNA, is mutagenic. Furthermore, a mutagenic can spike the frequency of mutations, which is way above the natural background level.

The group is addressing the FDA’s quest to see more data

Pharmacyte Biotech Inc is living up to the expectations of the U.S. Food and Drug Administration. The Chief Executive Officer of the company, Kenneth L. Waggoner, went on record to confirm that Pharmacyte Biotech Inc is working on addressing the FDA’s desire to see more data. Waggoner added that currently, a myriad of tests are in progress. He confirmed that data is generated as expected. The latest series of tests continue to back the safety claims made by CypCaps, which is PharmaCyte’s product candidate. The CEO went a step ahead and expressed confidence claiming that encapsulation material used for CypCaps is biocompatible, safe, and not toxic. He confirmed that every single test that Pharmacyte Biotech Inc is conducting confirms the claim.

Furthermore, the corporate house has confirmed that the respective performed by a third-party Contract Research Organization (CRO) was done following all the rules and regulations of the OECD Principles of Good Laboratory Practice. About four regulatory guidelines were adhered to while performing the research study. The study’s primary objective was to analyze and understand the impact of differently prepared extracts of empty capsule material.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business5 hours ago

Cannabix Technologies Inc (OTCMKTS: BLOZF) Announces that it Will Ship an Additional THC Breath Analyzer (THCBA) Unit to the site

Post Views: 12 Cannabix Technologies Inc (OTCMKTS: BLOZF) has announced that it is scaling up subject beta testing unit in...

Business5 hours ago

Pharmacyte Biotech Inc (NASDAQ: PMCB) Made an Official Statement that Encapsulation Material Does Not Change Cellular DNA

Post Views: 43 Pharmacyte Biotech Inc (NASDAQ: PMCB) has left the scientific and medical community thinking. The biotechnology company is...

Business5 hours ago

SLANG Worldwide Inc (OTCMKTS: SLGWF) Announces Entry Into West Virginia and Pennsylvania Markets

Post Views: 28 SLANG Worldwide Inc (OTCMKTS: SLGWF) has announced that it has entered the Pennsylvania and West Virginia markets...

Business5 hours ago

Harborside Inc (OTCMKTS: HBORF) Announces That it Will Be Registered as a U.S Company By the SEC

Post Views: 34 Harborside Inc (OTCMKTS: HBORF) has announced plans to amend its articles to remove conversion restrictions on multiple...

Business1 day ago

Halo Collective Inc (OTCMKTS: HCANF) Completes the Process of Issuing Securities, and the company Enters into Share Purchase Deal with Akanda Corp for a Senior Exchange Listing

Post Views: 19 Halo Collective Inc (OTCMKTS: HCANF) has announced that it has completed the issuance of its common shares....

Business1 day ago

Icanic Brands Company Inc (OTCMKTS: ICNAF) Announces Sale of its Sacramento Cultivation Facility to Crowco Management LLC for $2 Million

Post Views: 66 Icanic Brands Company Inc (OTCMKTS: ICNAF) is more than happy to share the good news of its...